Cidara Therapeutics Inc (CDTX)

Aug 20, 2025

Cidara Therapeutics Inc. Breaks Below Key Support LevelJuly 2025 Pullbacks & Momentum Based Trading Ideas - beatles.ru

Aug 20, 2025

Aug 18, 2025

Cidara Therapeutics: Promising Trials Amidst Financial Challenges - MSN

Aug 18, 2025

Aug 16, 2025

Will Cidara Therapeutics Inc. bounce back from current supportGold Moves & Capital Efficiency Focused Strategies - Newser

Aug 16, 2025

Aug 16, 2025

Comparing Cidara Therapeutics Inc. in custom built stock radarsPrice Action & Daily Stock Momentum Reports - Newser

Aug 16, 2025

Aug 16, 2025

What Fibonacci levels say about Cidara Therapeutics Inc. rebound2025 Volatility Report & Fast Entry and Exit Trade Plans - Newser

Aug 16, 2025

Aug 16, 2025

Is Cidara Therapeutics Inc. a candidate for recovery playAnalyst Downgrade & High Conviction Buy Zone Alerts - Newser

Aug 16, 2025

Aug 16, 2025

What MACD and RSI say about Cidara Therapeutics Inc.2025 Growth vs Value & Long-Term Growth Stock Strategies - Newser

Aug 16, 2025

Aug 16, 2025

What does recent volatility data suggest for Cidara Therapeutics Inc.Index Update & Fast Momentum Entry Tips - Newser

Aug 16, 2025

Aug 16, 2025

Is Cidara Therapeutics Inc. trending in predictive chart models2025 Bull vs Bear & Short-Term Trading Alerts - Newser

Aug 16, 2025

Aug 16, 2025

Comparing LakeShore Biopharma (NASDAQ:LSB) and Cidara Therapeutics (NASDAQ:CDTX) - Defense World

Aug 16, 2025

Aug 16, 2025

Why Cidara Therapeutics Inc. stock attracts strong analyst attentionQuarterly Market Review & Stepwise Trade Execution Plans - Newser

Aug 16, 2025

Aug 15, 2025

Published on: 2025-08-15 18:00:40 - Newser

Aug 15, 2025

Aug 15, 2025

Cidara Therapeutics Inc. stock trend outlook and recovery path2025 Technical Overview & Fast Momentum Stock Entry Tips - Newser

Aug 15, 2025

Aug 15, 2025

Cidara Therapeutics: A High-Conviction Biotech Play with Clear Path to FDA Phase 3 and Market Disruption - AInvest

Aug 15, 2025

Aug 15, 2025

Cidara Therapeutics: Still Big Catalysts Ahead Following Impressive Ph2b Readout (CDTX) - Seeking Alpha

Aug 15, 2025

Aug 15, 2025

Fund Update: MORGAN STANLEY added 875,198 shares of CIDARA THERAPEUTICS (CDTX) to their portfolio - Quiver Quantitative

Aug 15, 2025

Aug 15, 2025

Analyzing recovery setups for Cidara Therapeutics Inc. investorsEarnings Overview Summary & AI Powered Buy/Sell Recommendations - Newser

Aug 15, 2025

Aug 15, 2025

Published on: 2025-08-15 04:34:11 - Newser

Aug 15, 2025

Aug 14, 2025

Will Cidara Therapeutics Inc. stock split in the near future2025 Performance Recap & Risk Managed Trade Strategies - Newser

Aug 14, 2025

Aug 14, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Q2 2025 Earnings Call Transcript - MSN

Aug 14, 2025

Aug 13, 2025

What recovery options are there for Cidara Therapeutics Inc.July 2025 Short Interest & Low Risk High Reward Ideas - Newser

Aug 13, 2025

Aug 13, 2025

Cidara (CDTX) Q2 Cash Surges 163% - AOL.com

Aug 13, 2025

Aug 12, 2025

Cidara Therapeutics Inc. Pullback Analyzed — Is It Time to ExitMarket Entry and Exit Point Tips From Traders - beatles.ru

Aug 12, 2025

Aug 10, 2025

JMP Securities Raises Cidara Therapeutics (NASDAQ:CDTX) Price Target to $66.00 - Defense World

Aug 10, 2025

Aug 10, 2025

Cidara Therapeutics (NASDAQ:CDTX) Given Buy Rating at Needham & Company LLC - Defense World

Aug 10, 2025

Aug 10, 2025

Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $74.00 - Defense World

Aug 10, 2025

Aug 09, 2025

A Quick Look at Today's Ratings for Cidara Therapeutics(CDTX.US), With a Forecast Between $66 to $74 - 富途牛牛

Aug 09, 2025

Aug 08, 2025

Cidara Therapeutics 2024 Q2 Earnings Net Loss Widens by 569.5% - AInvest

Aug 08, 2025

Aug 08, 2025

What moving averages say about Cidara Therapeutics Inc.Free Smart Trade Plans With Risk Protection - Newser

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics price target raised to $74 from $54 at Needham - TipRanks

Aug 08, 2025

Aug 08, 2025

Guggenheim raises Cidara Therapeutics stock price target to $70 on FDA meeting progress - Investing.com Canada

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics Rallies On Promising Flu Drug Progress - Finimize

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics Reports Positive Trial Results and Financial Growth - TipRanks

Aug 08, 2025

Aug 08, 2025

Earnings call transcript: Sidera Therapeutics’ Q2 2025 innovation focus - Investing.com

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics: Q2 Earnings Snapshot - Manistee News Advocate

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics stock price target raised to $66 at Citizens JMP - Investing.com Australia

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics Inc (CDTX) Q2 2025 Earnings Call Highlights: Promising Clinical Trial ... - Yahoo Finance

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics Inc (CDTX) Q2 2025 Earnings Call Highlights: Promising Clinical Trial ... By GuruFocus - Investing.com Canada

Aug 08, 2025

Aug 07, 2025

Cidara Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025

Aug 07, 2025

Cidara Therapeutics 2024 Q2 Earnings Deepened Losses Amid Strong Clinical Progress - AInvest

Aug 07, 2025

Aug 07, 2025

Transcript : Cidara Therapeutics, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener

Aug 07, 2025

Aug 07, 2025

Cidara Therapeutics reports Q2 EPS ($1.65), consensus ($1.82) - TipRanks

Aug 07, 2025

Aug 07, 2025

Cidara Therapeutics Q2 net loss narrows - MarketScreener

Aug 07, 2025

Aug 07, 2025

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire

Aug 07, 2025

Aug 07, 2025

Spero leads infectious disease gains with 252% stock jump - BioWorld MedTech

Aug 07, 2025